Investigational Site Number 840417 — Roswell, Georgia

Investigational Site Number 840417 is a clinical research site located in Roswell, Georgia, United States 30076.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 840417 has participated in 1 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Roswell

Browse all research sites in Georgia · View every site in Roswell

• WellStar North Fulton Hospital
• North Fulton Regional Hospital Pain Center
• Endocrine Research Solutions
• Novo Nordisk Investigational Site
• Coastal Research Associates
• Research Site
• Endo Res Solutions Inc
• Northwest Behavioral Research Center
• GSK Investigational Site
• VisualEyes
• Atlanta North Gynecology
• Gastroenterology Consultants

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840417?

Investigational Site Number 840417 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840417 conducted?

Investigational Site Number 840417 has 1 clinical trials on record. Their work covers Type 2 Diabetes Mellitus.

Is Investigational Site Number 840417 accredited by Crixeo Clinical Trials?

Investigational Site Number 840417 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840417?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.